课题基金 / 基金详情

HCV-Specific Cellular Immunity in Acute Hepatitis C

HCV-Specific Cellular Immunity in Acute Hepatitis C
急性丙型肝炎中的 HCV 特异性细胞免疫
批准号:
7014194
负责人:
Christopher M. Walker
金额:
$39.99万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-06-30

项目摘要

项目成果

Christopher M. Walker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We recently demonstrated that successful resolution of acute hepatitis C in chimpanzees primes a protective memory T cell response. Depletion of memory CD8+ T cells with subset-specific antibodies immediately before re-infection resulted in prolonged viremia. Infections never resolved if CD4+ T cells were depleted. Indeed, without helper activity memory CD8+ T cells selected for escape mutations in MHC class I restricted epitopes of the virus. These results indicate an essential role for both T cell subsets in control of HCV replication but why they usually fail is not known. T cell responses appear to focus on a limited set of MHC class I and II epitopes at the point infection resolves and later broaden to include sub-dominant epitopes. Thus, while the response appears multi-specific, it effectively targets a limited set of dominant epitopes when virus replication (and errors by the RNA polymerase) are at a peak. Specific aim 1 is to determine if this causes mutational escape of dominant MHC class II epitopes. Mutational escape will be compared with other potential mechanisms of CD4+ T cell silencing including failure to expand, acquire function, or follow a normal differentiation program after antigen activation. MHC class II tetramer technology adapted to chimpanzees will facilitate the analysis. Specific aim 2 is to identify defects in CD8+ T cells during acute hepatitis C and to determine if they occur coincident with CD4+ T cell loss. Finally, specific aim 3 will test the limits of T cell protection against persistence by rechallenging immune animals with virus variants that contain adaptive mutations in dominant MHC class I and II epitopes. Our three specific aims are to: Specific Aim 1. Compare how mutational escape in MHC class II epitopes versus functional defects in CD4+ T cells contribute to persistence of HCV. Specific Aim 2. Determine how HCV-specific CD8+ T cells are inactivated during acute hepatitis C and whether these defects are precipitated by the sudden loss of CD4+ T cell help that is characteristic of infections that persist. Specific Aim 3. Determine if transmission of HCV variants containing escape mutations in dominant MHC class I or II epitopes can subvert protective memory T cell responses in immune chimpanzees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies to enhance vaccine-primed T cell immunity against HCV
  • 批准号:
    10797241
  • 项目类别:
  • 资助金额:
    $40.39万
  • 财政年份:
    2021
  • 负责人:
    Christopher M. Walker
  • 依托单位:
Strategies to enhance vaccine-primed T cell immunity against HCV
  • 批准号:
    10205550
  • 项目类别:
  • 资助金额:
    $35.31万
  • 财政年份:
    2021
  • 负责人:
    Christopher M. Walker
  • 依托单位:
Strategies to enhance vaccine-primed T cell immunity against HCV
  • 批准号:
    10409761
  • 项目类别:
  • 资助金额:
    $63.37万
  • 财政年份:
    2021
  • 负责人:
    Christopher M. Walker
  • 依托单位:
T Cell Immunity and HCV Infection Outcome
海外基金